Literature DB >> 21329899

Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance.

Andrew S Flett1, Jonathan Hasleton, Christopher Cook, Derek Hausenloy, Giovanni Quarta, Cono Ariti, Vivek Muthurangu, James C Moon.   

Abstract

OBJECTIVES: The aim of this study was to compare the reproducibility of 7 late gadolinium enhancement (LGE) quantification techniques across 3 conditions in which LGE is known to be important: acute myocardial infarction (AMI), chronic myocardial infarction (CMI), and hypertrophic cardiomyopathy (HCM).
BACKGROUND: LGE by cardiac magnetic resonance is the gold-standard technique for assessing myocardial scar. No consensus exists on the best method for its quantification, and research in this area is scant. Techniques include manual quantification, thresholding by 2, 3, 4, 5, or 6 SDs above remote myocardium, and the full width at half maximum (FWHM) technique. To date, LGE has been linked to outcome in 3 conditions: AMI, CMI, and HCM.
METHODS: Sixty patients with 3 LGE etiologies (AMI, n = 20; CMI, n = 20; HCM, n = 20) were scanned for LGE. LGE volume was quantified using the 7 techniques. Mean LGE volume, interobserver and intraobserver reproducibility, and impact on sample size were assessed.
RESULTS: LGE volume varied significantly with the quantification method used. There was no statistically significant difference between LGE volume by the FWHM, manual, and 6-SD or 5-SD techniques. The 2-SD technique generated LGE volumes up to 2 times higher than the FWHM, 6-SD, and manual techniques. The reproducibility of all techniques was worse in HCM than AMI or CMI. The FWHM technique was the most reproducible in all 3 conditions compared with any other method (p < 0.001). Use of the FWHM technique for LGE quantification in paired analysis would lead to at least a 60% reduction in required sample size compared with any other method.
CONCLUSIONS: Regardless of the disease under study, the FWHM technique for LGE quantification gives LGE volume mean results similar to manual quantification and is statistically the most reproducible, reducing required sample sizes by up to one-half.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21329899     DOI: 10.1016/j.jcmg.2010.11.015

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  200 in total

1.  Evaluation of quantification methods for left arial late gadolinium enhancement based on different references in patients with atrial fibrillation.

Authors:  Sung Ho Hwang; Yu-Whan Oh; Dae In Lee; Jaemin Shim; Sang-Weon Park; Young-Hoon Kim
Journal:  Int J Cardiovasc Imaging       Date:  2014-11-04       Impact factor: 2.357

2.  Time-dependency, predictors and clinical impact of infarct transmurality assessed by magnetic resonance imaging in patients with ST-elevation myocardial infarction reperfused by primary coronary percutaneous intervention.

Authors:  Suzanne de Waha; Ingo Eitel; Steffen Desch; Georg Fuernau; Philipp Lurz; Deniz Haznedar; Matthias Grothoff; Matthias Gutberlet; Gerhard Schuler; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2011-11-10       Impact factor: 5.460

3.  Relationship and prognostic value of microvascular obstruction and infarct size in ST-elevation myocardial infarction as visualized by magnetic resonance imaging.

Authors:  Suzanne de Waha; Steffen Desch; Ingo Eitel; Georg Fuernau; Philipp Lurz; Anja Leuschner; Matthias Grothoff; Matthias Gutberlet; Gerhard Schuler; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2012-06       Impact factor: 5.460

4.  The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation .

Authors:  Tomas G Neilan; Ravi V Shah; Siddique A Abbasi; Hoshang Farhad; John D Groarke; John A Dodson; Otavio Coelho-Filho; Ciaran J McMullan; Bobak Heydari; Gregory F Michaud; Roy M John; Rob van der Geest; Michael L Steigner; Ron Blankstein; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  J Am Coll Cardiol       Date:  2013-08-28       Impact factor: 24.094

5.  Quantitative assessment of myocardial fibrosis in an age-related rat model by ex vivo late gadolinium enhancement magnetic resonance imaging with histopathological correlation.

Authors:  Pascale Beliveau; Farida Cheriet; Stasia A Anderson; Joni L Taylor; Andrew E Arai; Li-Yueh Hsu
Journal:  Comput Biol Med       Date:  2015-08-08       Impact factor: 4.589

6.  Peri-infarct ischaemia assessed by cardiovascular MRI: comparison with quantitative perfusion single photon emission CT imaging.

Authors:  E Gerbaud; H Cochet; E Bullier; C Ragot; S H Gilbert; H Douard; Y Pucheu; F Laurent; P Coste; L Bordenave; M Montaudon
Journal:  Br J Radiol       Date:  2014-04-29       Impact factor: 3.039

Review 7.  Role of cardiac MRI in diabetes.

Authors:  Ravi V Shah; Siddique A Abbasi; Raymond Y Kwong
Journal:  Curr Cardiol Rep       Date:  2014-02       Impact factor: 2.931

8.  Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in hypertension and associated with left ventricular remodeling.

Authors:  Shuli Wang; Hongjie Hu; Minjie Lu; Arlene Sirajuddin; Jinghui Li; Jing An; Xiuyu Chen; Gang Yin; Tian Lan; Linlin Dai; Yan Zhang; Xiaorong Yin; Lei Song; Aimin Dang; Peter Kellman; Andrew E Arai; Shihua Zhao
Journal:  Eur Radiol       Date:  2017-04-24       Impact factor: 5.315

9.  Myocardial infarct segmentation and reconstruction from 2D late-gadolinium enhanced magnetic resonance images.

Authors:  Eranga Ukwatta; Jing Yuan; Wu Qiu; Katherine C Wu; Natalia Trayanova; Fijoy Vadakkumpadan
Journal:  Med Image Comput Comput Assist Interv       Date:  2014

10.  Neprilysin levels at the acute phase of ST-elevation myocardial infarction.

Authors:  Hugo Bernelin; Nathan Mewton; Salim Si-Mohamed; Pierre Croisille; Gilles Rioufol; Eric Bonnefoy-Cudraz; Philippe Douek; Nathalie Dufay; Camille Amaz; Claire Jossan; Michel Ovize; Thomas Bochaton
Journal:  Clin Cardiol       Date:  2018-12-10       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.